Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Oblenio Bio

Oblenio Bio

Series BUSobleniobio.com
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$62.0Msum of rounds with a disclosed amount only
Named investors
4
Financing history
1 rounds
  1. Jun 25, 2026
    Series B · $62.0M (disclosed)
    Pfizer Ventures (lead)Deep Track Capital (participant)GV (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development”
Investors on record
4 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jun 25, 2026
    Oblenio Bio announced Series B of $62,000,000, led by Pfizer Ventures
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
3 observations
Every observation on this company